CHAMPIONS ONCOLOGY, INC. (CSBR)

Import this data to Google Sheets with:

=jivedata("CSBR","financials")

Full statements spill as a table. For one cell: =jivedata("CSBR","Revenue") or =jivedata("CSBR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

CHAMPIONS ONCOLOGY, INC.

CSBR • CIK 0000771856

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$50,155	$56,944	$59,425	$60,662
Operating Income (Loss)	$-7,356	$4,553	$-1,140	$-1,022
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-7,308	$4,626	$-929	$-892
Income Tax Expense (Benefit)	$-32	$-75	$246	$243
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	$-1,175	$-1,135
Cost of Goods and Services Sold	$29,401	$28,389	$30,900	$30,439
Research and Development Expense	$9,544	$6,825	$9,084	$9,346
Selling and Marketing Expense	$7,064	$7,545	$9,318	$10,553
General and Administrative Expense	$11,067	$9,339	$11,152	$11,255
Gain (Loss) on Disposition of Property Plant Equipment	$-435	$-293	$-111	$-91
Operating Costs and Expenses	$57,511	$52,391	$60,565	$61,684
Other Nonoperating Income (Expense)	$48	$73	$211	$130
Weighted Average Number of Shares Outstanding, Basic	13,547,604	13,659,786	13,832,385	13,941,506
Weighted Average Number of Shares Outstanding, Diluted	13,547,604	14,266,781	13,832,385	13,832,385
Net Income (Loss) Attributable to Parent	$-7,276	$4,701	$-1,175	$-1,165
Net Income (Loss) Available to Common Stockholders, Diluted	—	$4,701	$-1,175	$-1,175
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants	—	606,995	0	0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,919,497	126,353	2,639,820	2,721,454

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Cash	$2,618	$9,785	$4,872	$4,872
Accounts Receivable, after Allowance for Credit Loss, Current	$9,526	$11,234	$13,178	$13,602
Operating Lease, Right-of-Use Asset	$6,252	$5,080	$3,697	$9,675
Prepaid Expense and Other Assets, Current	$1,495	$1,350	$1,169	$1,332
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$5,721	$4,375	$3,526	$3,787
Assets, Current	$13,639	$22,369	$19,219	$19,292
Other Assets, Noncurrent	$185	$185	$212	$201
Goodwill	$335	$335	$335	$335
Assets	$26,132	$32,344	$26,989	$33,290
Operating Lease, Liability, Noncurrent	$6,093	$4,634	$2,992	$9,886
Other Liabilities, Noncurrent	$401	$85	$7	$215
Liabilities	$28,035	$28,572	$22,921	$28,830
Stockholders' Equity Attributable to Noncontrolling Interest	—	—	$129	$567
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	—	—	$4,068	$4,460
Accounts Payable, Current	$5,800	$4,248	$6,903	$5,632
Accrued Liabilities, Current	$2,160	$2,556	$2,592	$2,676
Operating Lease, Liability, Current	$1,337	$1,471	$1,520	$635
Other Liabilities, Current	$150	$135	$79	$234
Contract with Customer, Liability, Current	$12,094	$15,443	$8,828	$9,552
Liabilities, Current	$21,541	$23,853	$19,922	$18,729
Common Stock, Value, Issued	$14	$14	$14	$14
Treasury Stock, Common, Value	$708	$708	$708	$708
Additional Paid in Capital, Common Stock	$83,384	$84,358	$85,700	$86,080
Retained Earnings (Accumulated Deficit)	$-84,593	$-79,892	$-81,067	$-81,493
Stockholders' Equity Attributable to Parent	$-1,903	$3,772	$3,939	$3,893
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	13,714,099	13,897,503	14,007,159	14,038,902
Common Stock, Shares, Outstanding	13,558,650	13,777,170	13,886,826	13,918,569

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	—	—	$-1,175	$-1,135
Net Cash Provided by (Used in) Operating Activities	$-6,137	$7,386	$-4,472	$-5,564
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-7,500	$7,167	$-4,913	$-5,967
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2,618	$9,785	$4,872	$-1,095
Share-based Payment Arrangement, Noncash Expense	$1,118	$654	$1,237	$1,795
Payments to Acquire Property, Plant, and Equipment	$836	$389	$564	$573
Depreciation, Depletion and Amortization, Nonproduction	$1,867	$1,640	$1,377	$1,333
Proceeds from Sale of Machinery and Equipment	—	—	$24	$24
Gain (Loss) on Disposition of Property Plant Equipment	$-435	$-293	$-111	$-91
Net Cash Provided by (Used in) Investing Activities	$-836	$-389	$-540	$-549
Gain (Loss) on Termination of Lease	—	—	$9	$9
Accounts Receivable, Credit Loss Expense (Reversal)	$476	$-272	$28	$47
Proceeds from Stock Options Exercised	$253	$320	$234	$262
Finance Lease, Principal Payments	$146	$150	$135	$116
Net Cash Provided by (Used in) Financing Activities	$-527	$170	$99	$146
Capital Expenditures Incurred but Not yet Paid	—	$197	$98	$-63
Increase (Decrease) in Accounts Receivable	$1,991	$1,436	$2,002	$4,175
Increase (Decrease) in Prepaid Expense and Other Assets	$167	$-144	$-200	$117
Increase (Decrease) in Other Noncurrent Assets	$169	$0	$16	$5
Increase (Decrease) in Accounts Payable	$465	$-1,749	$2,558	$722
Increase (Decrease) in Accrued Liabilities	$-109	$395	$37	$875
IncreaseDecreaseInOperatingLeaseLiability	$-1,169	$-1,324	$-1,586	$-1,467
Increase (Decrease) in Contract with Customer, Liability	$-683	$3,349	$-6,615	$-4,877

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CSBR","financials")

Full statements spill as a table. For one cell: =jivedata("CSBR","Revenue") or =jivedata("CSBR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.